The human CD2 (T11) molecule is a 50-kD surface glycoprotein expressed on >95To of thymocytes and virtually all peripheral T lymphocytes that mediates both adhesion between these cells and their cognate partners, as well as subsequent activation events . Specific combinations of antibodies against the surface-bound molecule can activate IL-2-dependent T cell proliferation, helper T cell function, and cytotoxicity by NK cells and CTL (1-3) in the absence ofcellular adhesion . In addition, thymocyte activation can be mediated via CD2 (4, 5). The role of CD2 in approximation ofT cells to various cell types, including human thymic epithelial cells, B cells, target cells, and sheep erythrocytes has been demonstrated to depend on direct interaction between CD2 and the broadly distributed human LFA-3 surface glycoprotein or its sheep homologue, T11TS (5-10) .
added, followed by incubation at 4°C for 30 min . Subsequently, 20 p.l of Jurkat cells were added, and after 5 min they were centrifuged at 800 rpm in a Sorvall RT6000, followed by incubation at 4°C for 1 h . The cell mixture was gently resuspended and mounted on glass slides with cover slips and rosette formation was assessed on a Zeiss photomicroscope.
Radiolabeled TI1 .2 Binding Assays. The purified recombinant soluble CD2 external domain molecule Tll, .2 was radioiodinated as follows : 50 pl Tll eX 2 (1 mg/ml) dialyzed against PBS was labeled with 10 kl of immobilized lactoperoxidase/glucose oxidase (Enzymobeads ; Bio-Rad Laboratories) in 40 mM sodium phosphate, pH 7 .2, 0 .4% glucose, and 1 MCi 1251 for 5 min . After quenching the reaction for 20 min with 20 mM sodium iodide and 0 .0270 sodium azide, 20 Al FCS was added and the free iodine was separated on a 1-ml Bio-Gel P-6 column (Bio-Rad Laboratories) conditioned with 0 .2M sodium phosphate, pH 7 .2, and 10% FCS and run in the same buffer.
Cold Competition Studies. 5 x 106 cpm radiolabeled Tll,.2 (2 .8 x 108 cpm/nmol) was added at 0 .1 pM to 1 .8 x 106 JY cells overlayed onto 0 .2 ml of a 1 .5 :1 mixture of dibutyl phthalate:dioctyl phthalate (Aldrich Chemical Co., Milwaukee, WI) in 0 .5-ml plastic tubes as described in Teshigawara et al. (23) . Increasing concentrations of unlabeled Tll,.2 or T4ex1 were added in a final volume of 200 Ftl in RPMI 1640/10% FCS . After a 1-h incubation at 4°C, the tubes were centrifuged (8,500 g for 1 min), the tips of the tubes containing the cell pellets were cut, and the cell-bound and free radioactivity were determined in a gamma counter. To some tubes, anti-LFA-3 antibody TS2/9 (generously provided by Dr. Timothy Springer, Dana Farber Cancer Institute, Boston, MA) was added at 50 jig/ml as a separate determination of nonspecific binding . This concentration of anti-LFA-3 was independently shown to give maximal inhibition of Tll,.2 binding . Specific activity was calculated using a molecular weight for Tll,.2 of 30,000 . Protein concentrations were determined by quantitative amino acid analysis of standard Tll, .2 samples . Subsequent samples were compared with standards by Coomassie blue staining of twofold dilutions of standard and test samples run on the same gel and analyzed by densitometry.
Saturation Binding Studies. Increasing concentrations of radiolabeled Tll ex2 (1 .31 x 10 7 cpm/nmol) were added to 2 .6 x 10 6 JY cells in the presence or absence of 50 Kg/ml anti-LFA-3 antibody to determine nonspecific binding. Binding was carried out as above and the dissociation constant was determined by Scatchard analysis after subtraction of nonspecific binding determined in the presence of anti-LFA-3 .
Results
Production and Purification of T11 ex2 . We designed a construct for expression of a soluble fragment of CD2 that would include all the residues encoded by the leader and two extracellular segment exons (Fig . 1, exons 1-3) . The plasmid pAc373/Tll eX 2 was constructed as described in Materials and Methods and encodes 182 amino acids of the predicted CD2 external segment including all the residues derived from the ^ acid residues -24 to -4, exon 2 to residues -4 to 103, exon 3 to residues 104 to 180, exon 4 to residues 181 to 221, and exon 5 to residues 222 to 327 (17) .
two extracellular exons ( Fig. 1) and part of one codon (for Glu-181) and all of a second codon (for Lys-182) derived from the transmembrane domain exon . This construction thus includes all four extracellular cysteine residues located in domain II of CD2 and thereby avoids problems associated with intermolecular disulfide exchange observed with a previous construction (24) . Plasmid pAc373/T11 e,,2 was used to co-transfect SF9 cells with AcNPV baculoviral DNA. Recombinant baculovirus, termed Tllex 2-AcNPV, were selected, purified, and used to infect small-scale cultures for metabolic labeling . Immunoprecipitation of radiolabeled supernatants with anti T11 t (3T4-8B5), an anti-CD2-specific mAb (1), verified that Tllex2-AcNPV directed the production of a recombinant CD2 molecule in SF9 cells (data not shown) . Tllex 2-AcNPV was therefore used to infect liter cultures for the production of large amounts of protein. T11, X2 protein was purified from infected cell supernatants by affinity chromatography on an antiT11 t column .
Biochemical Characterization of Tllex2. Tllex 2 migrates as a well-demarcated doublet in both reducing and nonreducing conditions in SDS-PAGE ( To investigate the difference between the two bands representing T11ex2, 160 pmol of purified protein was separated by SDS-PAGE and blotted onto a polyvinyl difluoride (PVDF) membrane (20) . The upper and lower bands were cut separately from the membrane for NH2-terminal sequencing . Each band yielded the CD2 NH2-terminal sequence, suggesting that they differ from one another by posttranslational modification . As shown in Fig. 2 , endoglycosidase digestion generates at least five distinct bands. After short digestion times, two new lower molecular weight species are generated (lanes f-k) . Some glycans on T11, .2 are apparently quite susceptible to digestion since even after simultaneous addition ofenzyme and SDS sample buffer, these new species are generated (lanef). After 1 h digestion, most ofthe T11ex2 protein is digested to a 25-kD species (lane i); overnight digestion results in complete digestion to a single band at 25-kD (lanej). Note that the band of approximately 45-kD size represents the Endo-F enzyme since it appears in lane k, where an equivalent amount of enzyme alone has been analyzed . The origin of the faint band at 48-kD in lane J is unclear.
To determine whether T11,x2 exists as a noncovalently linked multimer in aqueous solution, it was subjected to equilibrium sedimentation by the high-speed meniscus depletion method (21) in both aqueous and dissociating conditions . As shown in Fig. 3 , the calculated molecular weights for both conditions are very similar (25.3 kD in aqueous solution vs. 24.7 kD in dissociating conditions). This result demonstrates that T11,x2 exists as a monomer in solution .
The expression of CD2 epitopes was investigated by immunoprecipitation analysis. The Tllex2 molecule can be immunoprecipitated by both anti-T11, and a second mAb to a different epitope termed anti T112 . However, T11,x2 is not immunoprecipitated by the anti-CD2 antibody anti-T113, which defines an activation specific epitope on CD2. Nevertheless, T11,x2 was able to inhibit the binding of anti-T113-FITC to the T113+ Jurkat cell line at a concentration of 10 AM, implying its presence on T11ex2 (data not shown) . These results also suggest that the affinity of anti-T113 for its epitope is low. 
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FIGURE 3 . Equilibrium sedimentation analysis . Plots of log (fringe displacement) against square of distance from center of rotation, r 2. T11 ex 2 (0 .05%) was analyzed by sedimentation equilibrium on an analytical ultracentrifuge (model E; Beckman Instruments, Fullerton, CA) in aqueous solution (PBS) at 30,000 rpm (w = 3 .142 x 10 3 rad/s) or in dissociating conditions (6 M guanidine hydrochloride) at 44,000 rpm (w = 4 .608 x 10 3 rad/s). Data were obtained at 22°C (PBS) or 23°C (guanidine-hydrochloride) . Assuming a partial specific volume of 0 .725, the calculated molecular weight from the displayed slope and using the equation : molecular weight = 4 .606 RT slope/[w2 (1 -trw)] is 225,315 in aqueous solution . Assuming a partial specific volume (denoted as a) of 0 .725 -0.1 in 6 M guanidine-hydrochloride (22) , the calculated molecular weight is 24,736 in dissociating conditions . Secondary structure predictions suggest the presence of both a-helical and /3-sheet structure in the CD2 external domain (16) . To more directly predict secondary structural characteristics, the Tlle,,2 molecule was evaluated by circular dichroism. As shown in Fig. 4 A, the far ultraviolet CD spectrum of Tlle,2 in 10 mM of sodium phosphate shows a positive absorption maximum at about 200 nm (De = 0.459), a negative minimum at 215 nm (De = -1 .94), and a shoulder at 225 nm (Ae = -1 .0). When the T11,.2 molecule is reduced by 50 mM DTT and subsequently alkylated with iodoacetamide, the CD spectrum is substantially altered, pointing to a role for disulfide bridges in stabilizing secondary and tertiary structure (Fig . 4 B) . The fact that the spectrum of the nonreduced molecule reflects significant thermal denaturation at 80°C (Fig . 4 C) confirms that substantial secondary structure is present in soluble TlleX 2 . As expected, the pattern after thermal denaturation is the same for the reduced as for the nonreduced molecule (compare Fig. 4 , C and D) .
In its overall pattern, the CD spectrum resembles that for Thy-1 (25) , which is a well-recognized member of the Ig superfamily (26) and is therefore predicted to consist entirely of /3-sheet . However, the shoulder at 225 nm is absent from the Thy-1 profile. To obtain a more objective prediction of secondary structure from the CD spectrum, the digitalized absorption data (Table 1) were deconvoluted according to the inverse matrix method of Compton and Johnson (27) . The resulting predictions for proportions of secondary elements are: a-helix, 20%; antiparallel /3-sheet, 13%; parallel /3-sheet, 9% ; turn, 20% ; other, 46%. Since none of the proteins in the data set used to determine the matrix values are homologous to CD2, the predicted frac-.V 
i08 (° TABLE I Digitized Protein Circular Dichroism Spectrum for Tller2 from 184-260 nm at 2-nm Intervals Spectrum was taken in 10 mM sodium phosphate (pH 7.2) in a 1-mm cell at 22°C . Secondary structure predictions were calculated by taking dot products with inverse CD spectra for the five secondary structure categories as described previously (27) ; see To investigate the presence of protease-resistant domains in the Tllex 2 molecule, limited papain digestions were performed. 15 min of digestion at an enzyme/protein ratio of 1 :250 at 37°C yields a major band at 15 kD when analyzed by SDS-PAGE (data not shown) . Longer digestion times cause partial disappearance of the 15-kD band . Approximately 400 pmol of this 15-kD material was blotted onto PVDF and sequenced, yielding 19 unambiguous residues corresponding to the CD2 NH2 terminus. These results demonstrate that the COOH region of T11,,,2 is much less resistant to papain digestion that its NH2-terminal counterpart.
Tllex2 Inhibits Sheep Erythrocyte Rosetting We next tested the ability of Tll ex2 to interact with the CD2 ligand expressed on the surface of various cell types. The capacity of Tll ex2 to inhibit sheep erythrocyte rosetting with T lymphocytes was tested . Table II shows that rosetting is completely inhibited at concentrations of Tllex2 >5 AM ; half-maximal inhibition occurs between 0.63 and 1.25 AM Tllex2. Note that the anti-T111 (3T4-8B5) antibody abrogates rosetting at a concentration as low as 0.007 AM (Table II) . This results suggests that any direct interaction between the soluble Tllex2 molecule and the CD2 ligand is of relatively low affinity. 
Anti-CD2
For rosette formation, sheep erythrocytes were preincubated with soluble protein or antibody at the indicated concentrations for 1 h at 4°C followed by the addition of Jurkat cells, cocentrifugation, and a further 1-h incubation at 4°C . Rosettes were counted in a hemacytometer . Control value was the fraction of rosette formation in the absence of added protein . Anti-CD2 was the anti-T11 i antibody 3T4-8B5 .
TlleX2 Blocks the Binding ofAnti-LFA-3 mAb. To investigate whether T11, X2 could interact with a previously defined ligand for CD2 on human cells (9) , its ability to block the binding of anti-LFA-3 mAb TS9/2 (29) to LFA-3-bearing cells was tested . Specifically, anti-LFA-3 reactivity was measured by FACS analysis on the human B-lymphoblastoid line JY, which expresses high levels of LFA-3 . As shown in Table  III , preincubation ofJY cells with soluble CD4 does not affect this staining, whereas preincubation with 10 I.M TlleX2 causes a substantial decrease in observed fluorescence, reducing linear immunofluorescence from channel 120 to 30 .6 . This represents a reduction of 85% of specific anti-LFA-3 reactivity (calculated after subtraction of the background fluorescence of 13 .2 linear units) . Significant blocking is also seen at 1 j,M but not at 0.1 jM . Addition of the control soluble CD4 T4,.1 protein has no effect on anti-LFA-3 binding. Thus, by this measure as well as by inhibition of sheep erythrocyte rosetting, the affinity of Tll eX 2 for its ligand is apparently in the micromolar range. Mean fluorescence intensities were obtained on a linear scale from 0 to 250 .
Tllex2 Binds to LFA-3 on Human B Lymphoblastoid Cells. Since T11, .2 clearly inhibits sheep erythrocyte rosetting and blocks the binding of anti-LFA-3 antibody, we determined whether specific, saturable binding of Tll ex 2 to human cells bearing LFA-3 could be detected . Two types ofbinding assays were used . In the first, increasing amounts of unlabeled T11, X2 was added to a mixture of the JY B-lymphoblastoid cell line plus a constant amount of 1251-labeled Tll ex2 (ligand) . As shown in Fig.  5 , binding of radiolabeled T11ex2 is progressively inhibited by the addition of increasing amounts of unlabeled molecules. Half-maximal inhibition occurs at -0.5 14M of Tllex2 . In contrast and as expected, addition of soluble CD4 T4ex1 protein has no effect on 1251-labeled Tllex2 binding to JY After a 1-h incubation at 4°C, tubes were spun, cell pellets were severed, and bound radioactivity was determined . To one tube anti-LEA-3 antibody TS2/9 was added at 50,ug/ml as a determination of nonspecific binding. Specific cpm are the total cpm minus cpm bound in the presence of anti-LFA-3 (9,070 cpm) . Binding in the presence of control anti-HLA mAb W6/32 is also shown (triangle) . As a second measure of binding, increasing amounts of labeled Tllex2 were added to a constant number ofJY cells. As shown in Fig. 6 (top) , specific binding is saturable. These saturation binding data were transformed by Scatchard analysis (Fig. 6, bottom) . Specific T11ex2 binding is saturated at -300 x 10 3 molecules per cell. The Scatchard plot yields an estimated dissociation constant of 0.4 pM for the Tllex 2-LFA-3 interaction. Note that although a single incubation period (1 h at 4°C) of cells with ligand was used in these experiments, kinetic analysis demonstrates that maximal T1-1 e,2-LFA-3 binding occurs within 5 min.
Discussion
We have shown that a soluble, monomeric extracellular segment CD2 molecule, termed T11,.2, carries epitopes recognized by antibodies against the native surface CD2 structure on resting T lymphocytes and interacts specifically with the surfacebound CD2 ligand LFA-3. The measured dissociation constant for this interaction is 0 .4 uM, implying a low affinity relative to hormone receptor-ligand interactions (i .e ., for IL-2 Kd = 10 -11 M) (23) but equivalent to that of primary antibody responses (Kd = 10 -5 to 10 -6 ) (30) . The T11,X2 molecule gives rise to a proteolytically resistant 15-kD N112-terminal papain fragment, suggesting that the NH2-terminal -100 amino acid residues comprise a stable, well-folded domain corresponding to a polypeptide encoded by the first extracellular exon . In contrast, despite disulfide linkages, the COOH-terminal-encoded extracellular domain is labile to papain .
Binding ofMonomeric T11e,2 Is Less Avid than that ofDetergent-solubilized CD2. The dissociation constant presented here for the monomeric T11,X2 molecule contrasts with the value of 50 nM reported for similar analyses on JY cells with a detergentsolubilized full-length CD2 molecule purified from T cells (9) . In both cases the estimate of binding affinity derived by Scatchard analysis agrees quite well with that obtained by inhibition with unlabeled ligand . The two distinct interactions measured likely display real affinity differences . In addition, blocking estimates of the affinity of T11,X2 for its ligand by rosette inhibition, blocking of anti-LFA-3 antibody binding, either of two distinct radiolabeled binding assays and preliminary studies of T11,.2-mediated inhibition of clonal T cell proliferation (data not shown) all give results in the same range, i.e ., a distinctly lower affinity that that reported for detergent-solubilized CD2.
Several possibilities may explain the difference in reported binding affinities . First, the presence of the hydrophobic transmembrane segment in the purified CD2 molecule may endow it with a different binding behavior than the membrane-anchorless T11,%2 protein. For example, it is possible that interaction of the transmembrane segment with the cell Membrane affects the maximal affinity. Second, detergentsolubilized CD2 Probably exists as detergent/protein micelles, which might allow for a multivalent attachment of micelles to JY cells that could affect the observed dissociation constant : Such multipoint attachment would not be possible for the monomeric TIle.2 . However, one cannot rule out the possibility that T11ex2 fails to adopt a conformation`sufficiently like that of the native CD2 molecule to allow it to bind in a similar way. This might result from the absence of contributions from the transmembrane or cytoplasmic domains or differences in post-translational processing by SF9 cells as compared with human T lymphocytes. This possibility is made less likely by the fact that T11 e.2 carries epitopes for anti-CD2 antibodies that inhibit CD2-LFA-3 interaction and the unrelated T112 and T113 epitopes and by the fact that SF9 cells correctly cleave the CD2 signal peptide.
The relatively low affinity of T11,X2 for LFA-3 needs to be viewed in the context of the cell biology of this ligand-receptor pair in cell-cell interactions . Clearly, CD2 does not exist as a soluble monomer on T cells, but rather as an array of cell-bound transmembrane structures consisting of multiple copies per cell, ranging from 20,000 on resting peripheral blood lymphocytes to 200,000 on activated T cells (13) . Thus, a high affinity interaction between one CD2 and one LFA-3 molecule may not be required for a single binding event. Rather, a series of low affinity binding events could be sufficient for two cells to adhere to one another by a multimeric interaction that would greatly enhance the avidity of the T cell for its cognate partner. Antigenstimulated T cells express an order of magnitude more of surface CD2, perhaps in order to adhere better to presenting cells in areas of ongoing immune responses.
Substantial indirect evidence exists to suggest that the CD4 molecules on helper T cells and class II-restricted cytolytic T cells interact with class II MHC molecules on stimulator or target cells (31) (32) (33) . Abrogation of this interaction by anti-CD4 or anti-class II antibodies profoundly influences T cell responses. The inability to observe a direct physical interaction between CD4 and Ia and to inhibit cellular interactions with micromolar amounts of soluble CD4 (19) suggests that low affinity interactions are of fundamental significance for physiologic T cell function .
The Relationship of CD2 to the Ig Superfamily. Several reports argue for the inclusion of CD2 in the Ig superfamily (26, 34, 35) . The defining characteristic of members of this family is the presence of one or more Ig folds that comprise two 0-sheets, each containing three or four antiparallel a-strands, 5-10 amino acids in length . Nearly all Ig folds contain an intrachain disulfide link. The fold is markedly resistant to proteolysis which may reflect the need for Ig-like molecules to retain function in extracellular spaces where they may be exposed to proteases. Immune system molecules predicted to have at least one such domain include the MHC antigens, CD4 and CD8 structures, Thy-1 molecule, and poly-Ig receptor. A variety of cell surface molecules found on cells outside the immune system have also been suggested to belong to this family, including the NCAM and ICAM-1 cell adhesion molecules and platelet-derived growth factor and CSF-1 receptors (reviewed in reference 26).
The exon-intron organization of CD2 divides its external segment into two domains: I, amino acids 1-103; and II, amino acids 104-180. Consistent with this division, limited papain digestion of soluble CD2 molecule T11e.2 clearly demonstrates the existence of a stable NH2-terminal fragment of -100 residues . Both domains I and II have been suggested to adopt Ig structures on the basis of primary sequence homology with other Ig family members (26) .
Although the alignment scores for these domains are statistically significant when tested against other members of the Ig superfamily, certain difficulties are apparent . If both CD2 domains are Ig-like, the extracellular domain should not contain any a-helical structure. However, earlier secondary structural predictions suggest the presence of a-helices, with a particularly strong prediction for the NH2-terminal 10-20 residues (16) . In addition, circular dichroism data for the Tlle.2 molecule, which includes both domains, predict substantial (-20%) a-structure when analyzed by either of two deconvolution methods. If this interpretation of the CD profile is correct, and if Tll,.2 adopts a configuration similar to native CD2, as is suggested by its ability to be recognized by anti-CD2 antibodies and to bind specifically to a cellsurface ligand for CD2, LFA-3, it would appear unlikely that both CD2 domains adopt Ig folds.
Given that the 15-kD domain I fragment can be obtained in high yield from the soluble CD2 molecule described here, it should be informative to analyze the fragment alone by circular dichroism. Apparently, it also folds correctly since it can be recognized by anti-T111 and anti T112 antibodies and inhibits sheep erythrocyte rosetting to T cells (24) . If the secondary structure predictions (16) are correct, this analysis should reveal a mix of a-helical and /3-sheet structures . The availability of both the entire extracellular segment and the fragment in large amounts could also allow for crystallographic analysis.
The present report has emphasized the role of the CD2 external segment in facilitating T lineage-specific cell adhesion. Clearly, this C132-dependent process is critical for physiologic T cell function and thymocyte-thymic epithelial cell interaction . Given the lineage-restricted nature of the CD2 adhesion molecule and the high level of LFA-3 expression on thymic epithelial cells (5), it is quite likely that CD2 plays a major role in intrathymic differentiation .
Summary
The 50-kD CD2 (Tll) surface glycoprotein on human T lymphocytes and thymocytes plays a critical role in T lineage cell activation and adhesion via its ligand LFA-3. To begin to define structure-function relationships in the extracellular segment ofthe transmembrane CD2 molecule, we have used a eukaryotic expression system and a CD2 cDNA to produce milligram amounts ofrecombinant soluble CD2 molecule that corresponds to the two extracellular segment exons. We show that this protein, termed Tll e,2, behaves as a monomer in aqueous solution and includes a proteolytically resistant NH2-terminal fragment (domain I) encoded by the first extracellular segment exon. Circular dichroism analysis of T11 e,2 demonstrates that its stabilized secondary structure is dependent on the intrachain disulfide bonds present in domain II. The Tll,.2 monomer binds directly to the CD2 ligand LFA-3 with a dissociation constant of 0.4,uM . This relatively low affinity implies that cooperative binding resulting from an array oftransmembrane CD2 molecules is important to facilitate physiologic T cell adhesion.
